Have a symptom?
See what questions
a doctor would ask.
News » New treatment for esophageal cancer involves laser light

New treatment for esophageal cancer involves laser light

A novel treatment is now available in some places for treatment of esophageal carcinoma. The treatment, called Photodynamic Therapy (PDT), involves treating the cancer cells with photosensitive drugs and then applying red laser light to destroy the target cells. The therapy is highly effective for treating Barrett's esophagus which usually develops in GERD patients. Traditionally, surgical esophagectomy was the only treatment available and it required a 3-4 week hospital stay. The new therapy is much quicker and cheaper and less invasive. Surgery has a complication rate of 29% and costs more than $88,000 compared to PDT which is about $35,000. Side effects of PDT include nausea, mild constipation, chest discomfort and a constricted feeling in throat. A major side effect of the treatment is extreme light sensitivity which means that treated patients must virtually totally avoid direct and indirect sunlight for a minimum of six weeks. The treatment is not suitable for people who have had previous high-dose radiotherapy treatment, have poor pulmonary function, have multifocal or multilobar disease as well as certain other conditions. 10-15% of GERD sufferers eventually develop Barrett's esophagus of which only 1-2% develop into esophageal cancer. 13,000 new cases of esophageal cancer are diagnosed annually and it causes 12,500 deaths annually.

Source: summary of medical news story as reported by Kansas City Nursing News

Related Disease Topics:

Article Source Details

About: New treatment for esophageal cancer involves laser light

Date: 3 January 2005

Source: Kansas City Nursing News

Author: Lisa Waterman Gray


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Traditional breast cancer pill no longer the best choice
  • Traditional herbal remedies being studied provide positive results
  • Trans fats may cause memory and learning decline
  • Treatment being developed for female sexual dysfunction
  • Treatment may now be possible for early diagnosed cases of Niemann-Pick disease
  • Treatment options are available for excessive menstrual bleeding
  • Trials involving epilepsy drug as obesity and diabetes treatment cease over safety concerns
  • Trials with mice shows hope for human muscular dystrophy sufferers.
  • Trichotillomania is a rare compulsive hair pulling disorder
  • Triple test proposed for prostate cancer screening

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise